Mulcahy D, Fitzgerald M, Wright C, Sparrow J, Pepper J, Yacoub M, Fox K M
Royal Brompton National Heart and Lung Hospital, London.
BMJ. 1993 Jan 9;306(6870):98-101. doi: 10.1136/bmj.306.6870.98.
To assess long term survival (> 5 years) and quality of life in severely ill patients referred for urgent cardiac transplantation.
Tertiary referral centres: before transplantation at the National Heart Hospital (late 1984 to end 1986); after transplantation at Harefield Hospital.
Eighteen patients (15 men; three women) who had required intensive support in hospital before cardiac transplantation and were alive at short term follow up.
Intravenous infusions of cardiac drugs (mean 2.2 infusions), intravenous diuretics (17 patients), and many other drugs before transplantation. Intra-aortic balloon counterpulsation (four patients), temporary pacing (two), and resuscitation from cardiac arrest (three). Patients had specialised nursing care on a medical intensive care unit in almost every case.
Long term survival in patients after urgent cardiac transplantation and perceived quality of life.
Of 18 patients who were alive at short term follow up (mean (range) 19.4 (10-33) months), 14 were still alive in 1992 (69 (61-83) months). Ten still worked full time, and 11 reported no restrictions in their daily activities. Three of four patients who died in the intervening period survived > 5 years after transplantation. Overall, 17 of 18 patients survived at least 5 years.
In severely ill patients who undergo urgent cardiac transplantation and survive in the short term, long term (5-7 year) survival and quality of life seem good.
评估因紧急心脏移植而转诊的重症患者的长期生存情况(>5年)和生活质量。
三级转诊中心:在国家心脏医院移植前(1984年末至1986年末);在 Harefield 医院移植后。
18名患者(15名男性;3名女性),他们在心脏移植前需要在医院接受强化支持,且在短期随访时仍存活。
移植前静脉输注心脏药物(平均2.2次输注)、静脉利尿剂(17名患者)以及许多其他药物。主动脉内球囊反搏(4名患者)、临时起搏(2名)以及心脏骤停复苏(3名)。几乎所有患者都在医疗重症监护病房接受了专门护理。
紧急心脏移植患者的长期生存情况和感知生活质量。
在短期随访时存活的18名患者中(平均(范围)19.4(10 - 33)个月),1992年时14名仍存活(69(61 - 83)个月)。10名仍全职工作,11名报告日常活动无限制。在此期间死亡的4名患者中有3名在移植后存活>5年。总体而言,18名患者中有17名至少存活了5年。
对于接受紧急心脏移植且短期存活的重症患者,长期(5 - 7年)生存情况和生活质量似乎良好。